Condition: Recurrent Urinary Tract Infection · Sponsor: Hvidovre University Hospital
Investigate the effect of dietary supplements/probiotic ASTARTE™ ( L. crispatus, L. rhamnosus, L. jensenii, L. gasseri) on the microbiome composition in the intestine and vagina and thereby a reduction of risk factors for the development of rUTI during 6 months of intervention in women aged 18-40 years. This is measured by the incidence of symptomatic UTI.
This description comes directly from the study's public registry record.
Andreas Petersen, DM. PhD · +4538626199 · andreas.munk.petersen@regionh.dk
Khaled Ghathian, phd.stud. · +38623205 · khaled.saoud.ali.ghathian@regionh.dk
Always discuss trial participation with your own doctor first.
| Gastrounit, Copenhagen University Hospital Hvidovre | Hvidovre, Copenhagen, Denmark | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05553652